Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interleukin-6 (Homo sapiens (Human)) | BDBM414420 ((R)-7-[4-(2-ethoxycarbonyl-2-hydroxyethyl)oxy-2-me...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331838 ((R)-7-[4-(2-ethoxycarbonyl-2-hydroxyethyl)oxy-2-me...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140015 (US8901310, Comparator E) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140013 (US8901310, Comparator C) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140014 (US8901310, Comparator D) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140017 (US8901310, Comparator G) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140019 (US8901310, Comparator I) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM65497 (CC-220 (Compound 6) | US9694015, 6.4S) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | 37 |
Celgene Corporation US Patent | Assay Description The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p... | US Patent US9694015 (2017) BindingDB Entry DOI: 10.7270/Q2R49NZN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140012 (US8901310, Comparator B) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM19190 ((1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem Patents Similars | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140018 (US8901310, Comparator H) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140016 (US8901310, Comparator F) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM77001 (3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid PDB UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | 37 |
Celgene Corporation US Patent | Assay Description The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p... | US Patent US9694015 (2017) BindingDB Entry DOI: 10.7270/Q2R49NZN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331841 ((S)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331841 ((S)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331840 ((R)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331840 ((R)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331839 ((S)-7-[4-(2,4-dihydroxybutyl)oxy-2-methoxyphenyl]-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331839 ((S)-7-[4-(2,4-dihydroxybutyl)oxy-2-methoxyphenyl]-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331836 ((S)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331836 ((S)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331837 ((R)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331837 ((R)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140011 (US8901310, Comparator A) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | >36.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM65456 (19171-19-8 | 4-amino-2-(2,6-dioxopiperidin-3-yl)is...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase DrugBank MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | 37 |
Celgene Corporation US Patent | Assay Description The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p... | US Patent US9694015 (2017) BindingDB Entry DOI: 10.7270/Q2R49NZN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM76986 (3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-pipe...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | 37 |
Celgene Corporation US Patent | Assay Description The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p... | US Patent US9694015 (2017) BindingDB Entry DOI: 10.7270/Q2R49NZN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140010 (US8901310, Example 2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM77015 ((R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoi...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | 37 |
Celgene Corporation US Patent | Assay Description The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p... | US Patent US9694015 (2017) BindingDB Entry DOI: 10.7270/Q2R49NZN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331842 (7-[4-(3-t-butoxycarbonyl-2-hydroxypropyl)oxy-2-met...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331842 (7-[4-(3-t-butoxycarbonyl-2-hydroxypropyl)oxy-2-met...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331844 (8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxy-2-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331844 (8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxy-2-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331843 (8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 123 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331843 (8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 123 | n/a | n/a | n/a | n/a | n/a | n/a |
SANTEN PHARMACEUTICAL CO., LTD. US Patent | Assay Description 1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi... | US Patent US10435379 (2019) BindingDB Entry DOI: 10.7270/Q2X350TP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM50349518 (BERGENIN) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase MCE KEGG PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 208 | n/a | n/a | n/a | n/a | n/a | n/a |
CSIR-Indian Institute of Integrative Medicine Curated by ChEMBL | Assay Description Inhibition of IL6 (unknown origin) | Bioorg Med Chem 25: 5513-5521 (2017) Article DOI: 10.1016/j.bmc.2017.08.011 BindingDB Entry DOI: 10.7270/Q20004JF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM140020 (US8901310, Comparator J) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 291 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len... | US Patent US8901310 (2014) BindingDB Entry DOI: 10.7270/Q2MC8XQM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM65454 (191732-72-6 | CC-5013 | Lenalidomide | Revimid | R...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase DrugBank MCE PC cid PC sid PDB UniChem Similars | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Celgene Corporation US Patent | Assay Description The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p... | US Patent US9694015 (2017) BindingDB Entry DOI: 10.7270/Q2R49NZN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM50252381 (CHEMBL4080826) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea. Curated by ChEMBL | Assay Description Inhibition of IL-6 signaling pathway in human HepG2 cells transfected with p-STAT3-Luc assessed as reduction in IL-6 induced STAT3 phosphorylation pr... | Bioorg Med Chem 25: 3127-3134 (2017) Article DOI: 10.1016/j.bmc.2017.03.072 BindingDB Entry DOI: 10.7270/Q2KW5JF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM50070114 ((+/-)-thalidomide | 2-(2,6-Dioxo-piperidin-3-yl)-i...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem Patents Similars | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
Celgene Corporation US Patent | Assay Description The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p... | US Patent US9694015 (2017) BindingDB Entry DOI: 10.7270/Q2R49NZN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM50252380 (CHEMBL4068283) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.89E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea. Curated by ChEMBL | Assay Description Inhibition of IL-6 signaling pathway in human HepG2 cells transfected with p-STAT3-Luc assessed as reduction in IL-6 induced STAT3 phosphorylation pr... | Bioorg Med Chem 25: 3127-3134 (2017) Article DOI: 10.1016/j.bmc.2017.03.072 BindingDB Entry DOI: 10.7270/Q2KW5JF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM50252382 (CHEMBL4103291) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea. Curated by ChEMBL | Assay Description Inhibition of IL-6 signaling pathway in human HepG2 cells transfected with p-STAT3-Luc assessed as reduction in IL-6 induced STAT3 phosphorylation pr... | Bioorg Med Chem 25: 3127-3134 (2017) Article DOI: 10.1016/j.bmc.2017.03.072 BindingDB Entry DOI: 10.7270/Q2KW5JF6 | |||||||||||
More data for this Ligand-Target Pair |